González-González R, Molina-Frechero N, Damian-Matsumura P, Bologna-Molina R. Molecular markers
of cell adhesion in ameloblastomas. An update. Med Oral Patol
Oral Cir Bucal. 2014 Jan 1;19 (1):e8-14.
doi:10.4317/medoral.19071
http://dx.doi.org/doi:10.4317/medoral.19071
|
1. Thomas
GJ, Speight PM. Cell adhesion molecules and oral cancer. Crit Rev Oral Biol Med. 2001;12:479-98. |
||||
|
|
||||
|
2. Okegawa T, Pong RC, Li Y, Hsieh JT. The role of cell
adhesion molecule in cancer progression and its application in cancer
therapy. Acta Biochim Pol. 2004;51:445-57. |
||||
|
|
||||
|
3. Lesot H, Brook AH. Epithelial histogenesis
during tooth development. Arch Oral Biol. 2009;54 Suppl 1:S25-33. |
||||
|
|
||||
|
4. Costa
P, Parsons M. New insights into the dynamics of cell adhesions. Int Rev Cell Mol Biol. 2010;283:57-91. |
||||
|
|
||||
|
5. Philipsen HP, Reichart PA.
Classification of odontogenic tumours.
A historical review. J Oral Pathol Med. 2006;35:525-9. |
||||
|
|
||||
|
6. Zhong Y, Guo W, Wang L, Chen X.
Molecular markers of tumor invasiveness in ameloblastoma:
An update. Ann Maxillofac Surg. 2011;1:145-9. |
||||
|
|
||||
|
7. Brieher WM, Yap AS. Cadherin
junctions and their cytoskeletons(s). Curr Opin Cell Biol. 2013;5:39-46. |
||||
|
|
||||
|
8. Takeichi M. Cadherin cell
adhesion receptors as a morphogenic regulator. Science. 1991;251:1451-55. |
||||
|
|
||||
|
9.
Palacios J, Benito N, Berraquero R, Pizzarro A, Cano A, Gamallo C. Differential
spatiotemporal expression of E- and P-cadherin
during mouse tooth development. Int J Dev Biol. 1995;39:663-6. |
||||
|
|
||||
|
10. Alves Pereira KM, do Amaral
BA, dos Santos BR, Galvão HC, Freitas Rde A, de Souza LB. Immunohistochemical expression of E-cadherin and beta-catenin in ameloblastomas and tooth germs. Oral Surg
Oral Med Oral Pathol Oral Radiol
Endod. 2010;109:425-31. |
||||
|
|
||||
|
11. Auerkari EI. Methylation of
tumor suppressor genes p16(INK4a),p7(Kip1) and E-cadherin in carcinogenesis. Oral Oncol. 2006;42:5-13. |
||||
|
|
||||
|
12. Abiko
Y, Nagayasu H, Takeshima
M, Yamazaki M, Nishimura
M, Kusano K, et al. Ameloblastic carcinoma ex ameloblastoma: report of a case-possible involvement of CpG island hypermethylation of
the p16 gene in malignant transformation. Oral Surg
Oral Med Oral Pathol Oral Radiol
Endod. 2007;103:72-6. |
||||
|
|
||||
|
13. Nodit L, Barnes L, Childers E, Finkelstein S, Swalsky P, Hunt J. Allelic loss of tumor suppressor genes
in ameloblastic tumors. Mod Pathol.
2004;17:1062-7. |
||||
|
|
||||
|
14. Bánkfalvi A, Krassort M, Végh A, Felszeghy E, Piffkó J. Deranged expression of the E-cadherin/beta-catenin complex
and the epidermal growth factor receptor in the clinical evolution and
progression of oral squamous cell carcinomas. J
Oral Pathol Med. 2002;31:450-7. |
||||
|
|
||||
|
15. Logan
CY, Nusse R. The Wnt
signaling pathway in development and disease. Annu
Rev Cell Dev Biol. 2004;20:781-810. |
||||
|
|
||||
|
16. Siriwardena BS, Kudo Y, Ogawa
I, Tilakaratne WM, Takata
T. Aberrant beta-catenin expression and adenomatous polyposis coli gene
mutation in ameloblastoma and ondontogenic
carcinoma. Oral Oncol. 2009;45:103-8. |
||||
|
|
||||
|
17. Tanahashi J, Daa T, Yada N, Kashima K, Kondoh Y,
Yokoyama S. Mutational analysis of Wnt signaling
molecules in ameloblastoma with aberrant nuclear
expression of beta-catenin. J Oral Pathol Med. 2008;37:565-70. |
||||
|
|
||||
|
18. Uchino
M, Kojima H, Wada K,
Imada M, Onoda F, Satofuka
H, et al. Nuclear
beta-catenin and CD44 upregulation
characterize invasive cell populations in non-aggressive MCF-7 breast cancer
cells. BMC Cancer. 2010;10:414. |
||||
|
|
||||
|
19.
Kumamoto H, Ooya K. Expression of E-cadherin and alpha-catenin in epitelial odontogenic tumors:
an immunohistochemical study. J Oral Pathol Med. 1999;28:152-7. |
||||
|
|
||||
|
20. Saunders
S, Jalkanen M, O'Farrell S, Bernfield
M. Molecular cloning of syndecan, an integral
membrane proteoglycan. J Cell Biol. 1989;108:1547-56. |
||||
|
|
||||
|
21. Al-Otaibi O, Khounganian R, Anil
S, Rajendran R. Syndecan-1 (CD 138) surface
expression marks cell type and differentiation in ameloblastoma,
keratocystic odnotogenic
tumor, and dentigerous cyst. J Oral Pathol Med. 2013;42:186-93. |
||||
|
|
||||
|
22. Nikolova V, Koo CY, Ibrahim SA, Wang Z, Spillmann D, Dreier R, et al. Differential roles for
membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression. Carcinogenesis.
2009;30:397-407. |
||||
|
|
||||
|
23. Filla MS, Dam P, Rapraeger AC.
The cell surface proteoglycan syndecan-1 mediates
fibroblast growth factor-2 binding and activity. J Cell Physiol. 1998;174:310-21. |
||||
|
|
||||
|
24. Salmivirta M, Elenius K, Vainio S, Hofer U, Chiquet-Ehrismann
R, Thesleff I, et al. Syndecan
from embryonic tooth mesenchyme binds tenascin. J Biol Chem. 1991;266:7733-9. |
||||
|
|
||||
|
25. Anttonen A, Kajanti M, Heikkilä P, Jalkanen M, Joensuu H. Syndecan-1 expression has prognostic
significance in head and neck carcinoma. Br J Cancer. 1999;79:558-64. |
||||
|
|
||||
|
26.
Matsumoto A, Ono M, Fujimoto Y, Gallo RL, Bernfield
M, Kohgo Y. Reduced expression of syndecan-1 in
human hepatocellular carcinoma with high metastatic
potential. Int J Cancer. 1997;74:482-91. |
||||
|
|
||||
|
27. Pulkkinen JO, Penttinen M, Jalkanen M, Klemi P, Grénman R. Syndecan-1: a new prognostic marker in
laryngeal cancer. Acta Otolaryngol.
1997;117:312-5. |
||||
|
|
||||
|
28. Bologna-Molina
R, Mosqueda-Taylor A, Lopez-Corella E, Almeida OP,
Carrasco-Daza D, Garcia-Vazquez F, et al. Syndecan-1 (CD138) and Ki-67
expression in different subtypes of ameloblastomas.
Oral Oncol. 2008;44:805-11. |
||||
|
|
||||
|
29. Bologna-Molina
R, Mosqueda-Taylor A, Lopez-Corella E, de Almeida
OP, Carrasco-Daza D, Farfán-Morales JE, et al. Comparative expression of syndecan-1 and Ki-67
in peripheral and desmoplastic ameloblastomas
and ameloblastic carcinoma. Pathol Int. 2009;59:229-33. |
||||
|
|
||||
|
30. Lanier
LL, Chang C, Azuma M, Ruitenberg JJ, Hemperly JJ, Phillips JH. Molecular and functional
analysis of human natural killer cell-associated neural cell adhesion
molecule (N-CAM/CD56). J Immunol.
1991;146:4421-6. |
||||
|
|
||||
|
31. Er N, Dağdeviren A, Taşman F, Zeybek D. Neural
cell adhesion molecule and neurothelin expression
in human ameloblastoma. J Oral Maxillofac Surg.
2001;59:900-3. |
||||
|
|
||||
|
32. Cairns
L, Naidu A, Robinson CM, Sloan P, Wright JM, Hunter KD. CD56 (NCAM)
expression in ameloblastomas and other odontogenic lesions. Histopathology. 2010;57:544-8. |
||||
|
|
||||
|
33. Heikinheimo K, Morgan PR, Happonen
RP, Stenman G, Virtanen I. Distribution of
extracellular matrix proteins in odontogenic tumours and developing teeth. Virchows
Arch B Cell Pathol Incl
Mol Pathol.1991;61:101-9. |
||||
|
|
||||
|
34. Liotta LA, Kohn EC. The microenviroment
of the tumour-host interface. Nature. 2001;411:375-9. |
||||
|
|
||||
|
35. Modolo
F, Martins MT, Loducca
SV, de Araújo VC. Expression of integrin
subunits alpha2, alpha3, alpha5, alphav, beta1,
beta3, and beta4 in different histological types of ameloblastoma
compared with dental germ, dental lamina and adult lining epithelium. Oral Dis. 2004;10:277-82. |
||||
|
|
||||
|
36. Souza Andrade ES, da Costa
Miguel MC, Pinto LP, de Souza LB. Ameloblastoma and adenomatoid odontogenic tumor: the role of alpha2beta1, alpha3beta1,
and alpha5beta1 integrins in local invasiveness and
architectural characteristics. Ann Diagn Pathol. 2007;11:199-205. |
||||
|
|
||||
|
37.
Marshall JF, Hart IR. The role of alpha av-integrins
in tumour progression and metastasis. Semin Cancer Biol. 1996;7:129-38. |
||||
|
|
||||
|
38. Bello
IO, Soini Y, Slootweg PJ,
Salo T. Claudins 1, 4, 5,
7 and occludin in ameloblastomas
and developing human teeth. J Oral Pathol Med. 2007;36:48-54. |
||||
|
|
||||
|
39. Kominsky
SL, Argani P, Korz D, Evron E, Raman V, Garrett E, et
al. Loss of
the tight junction protein claudin-7 correlates with histological grade in
both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene. 2003;22:2021-33. |
||||
|
|
||||